sacituzumab govitecan for treatment-refractory metastatic breast cancer
Published 5 years ago • 669 plays • Length 3:59Download video MP4
Download video MP3
Similar videos
-
1:34
sacituzumab govitecan effective for hr metastatic breast cancer regardless of trop-2 status
-
3:10
ascent trial: sacituzumab govitecan for tnbc
-
2:02
sacituzumab govitecan in the treatment of metastatic urothelial carcinoma
-
1:36
real-word efficacy of sacituzumab govitecan in metastatic triple-negative breast cancer
-
4:25
ascent: sacituzumab govitecan shows promise in mtnbc patients
-
1:49
final os analysis of sacituzumab govitecan in tropics-02
-
1:08
ascent-05: sacituzumab govitecan and pembrolizumab in tnbc
-
1:00
tropics-02: sacituzumab govitecan in hr /her- breast cancer
-
5:07
tropics-02: sacituzumab govetican improves pfs versus physicians choice for hr /her2- mbc
-
1:58
ascent-04: sacituzumab govitecan and pembrolizumab in pd-l1-positive tnbc
-
2:38
trophy-u-01 cohort 3: sacituzumab govitecan pembrolizumab for patients with muc
-
1:39
treatment for her2 metastatic breast cancer
-
3:59
sacituzumab govitecan increases pfs for hr /her2- metastatic breast cancer
-
2:16
efficacy of sacituzumab govitecan by trop-2 expression in patients with muc
-
1:45
comment: sacituzumab govitecan for hr /her2‐ advanced breast cancer
-
2:15
ascent: sacituzumab govitecan biomarker analysis
-
2:57
efficacy of sacituzumab govitecan in muc by trop-2 expression
-
1:55
tropics-03: sacituzumab govitecan as a 2l treatment for es-sclc
-
3:53
sacituzumab govitecan in metastatic urothelial carcinoma: updates on the phase ii study